Professional Society for Health Economics and Outcomes Research (ISPOR), 2024
Leading global conference discussing how to establish, incentivize, and share value sustainable for health systems, patients, and technology developers.
U.S. Medical
This site is intended for U.S. Healthcare Professionals.
To report an adverse event or product quality complaint, call 1-877-TAKEDA-7 (1-877-825-3327)
Not an actual patient.
The incidence and prevalence of eosinophilic esophagitis have steadily increased over time. Approximately 1 in 2000 people in the U.S. live with EoE.2,3 EoE is often accompanied by other comorbidities, and has a strong association with atopic disease.1,4,5 Clinicians should maintain a high index of suspicion of EoE, regardless of age, race or sex; however, EoE is approximately twice as common in men vs women and more common among White people, with symptoms varying by age.6
The diagnosis of EoE is dependent on clinical, endoscopic, and histologic findings. These findings include symptoms of esophageal dysfunction; endoscopic findings of rings, furrows, exudates, edema, stricture, narrowing, and crepe-paper mucosa; and eosinophilic infiltration, which is defined as ≥15 eosinophils per high power field (eos/hpf) on an esophageal biopsy, that is isolated to the esophagus.7 A diagnosis of EoE is not reliant on prior response to proton pump inhibitors (PPIs). EoE should be suspected if a patient presents with chronic signs and symptoms of esophageal dysfunction such as: dysphagia, food impaction, food refusal, failure to progress with food introduction, heartburn, regurgitation, vomiting, chest pain, odynophagia, abdominal pain and malnutrition.
The pathophysiology of EoE involves the production of pro-inflammatory cytokines that promote the recruitment and proliferation of immune effector cells, such as eosinophils, at the site of inflammation. This chronic inflammation, localized to the esophagus can disrupt normal epithelial integrity.2,8,9 If left untreated, the disease can progress to a fibrostenotic phenotype with esophageal remodeling and dysmotility.1,10,11
The symptoms and impact of EoE can vary by age.1,12 Infants and toddlers with EoE may experience vomiting, food refusal, choking with meals, and sleep disturbances. Children may experience dysphagia, choking and gagging with certain foods, food impactions, pain, nausea and vomiting, sleep disturbances, and decreased appetite. Adults may report dysphagia, food impaction, food avoidance, intractable heartburn, regurgitation, and chest pain. Surveys of patients with EoE suggest their greatest concerns relate to difficulty swallowing and the overall impact on eating.13,14 Symptomatic improvement has been shown to be a key endpoint of therapy.15,16
Medication Resources
(budesonide oral suspension)
Leading global conference discussing how to establish, incentivize, and share value sustainable for health systems, patients, and technology developers.
Global meeting for physicians, researchers, and industry in the fields of gastroenterology, hepatology, endoscopy, and gastrointestinal surgery.
Annual forum for participants to learn about the latest advances in pediatric gastroenterology, hepatology, and nutrition, and to discuss current topics in clinical applications.
Large assembly of pharmacy and healthcare professionals dedicated to the issues of managed care pharmacy, offering immersive education sessions and keynote presentations.
Annual global conference for interdisciplinary, clinical nutrition leaders, providing the latest in clinical nutrition research, education, and products.
Annual conference for a multidisciplinary community of practitioners and researchers focusing on inflammatory bowel disease (IBD) by pairing best practices in clinical care with innovative research.
An all-encompassing event providing real-world clinical education, case studies and new evidence-based approaches in IBD management.
Premier event for clinicians and the general public about digestive disorders and the latest trends in GI technology and therapeutics.
Annual event with more than 2,500 members and non-members of the AMCP to engage on the latest innovations and most intentional networking in managed care pharmacy.
Global congress for researchers from around the world to present their findings on gastroenterology and digestive health.
Annual forum for participants to learn about the latest advances in pediatric gastroenterology, hepatology, and nutrition and to discuss current topics in clinical applications.
Annual global congress dedicated to clinical nutrition and metabolism, including basic and clinical research, education, and organization of consensus statements about clinical care.
Annual meeting uncovering cutting-edge research ranging from basic neurogastroenterology, translational and clinical aspects of gastrointestinal motility, and functional disorders.
Bi-annual congress promoting intestinal rehabilitation and transplantation as a safe, innovative science involving nutritional, medical, surgical and transplant therapies through education, policy development and research.
Annual congress discussing innovative treatments and research discoveries to enhance the standards of care for patients and help pediatric gastroenterology, hepatology, and nutrition professionals improve their practice.
Leading global conference discussing how to establish, incentivize, and share value sustainable for health systems, patients, and technology developers.
Global meeting for physicians, researchers, and industry in the fields of gastroenterology, hepatology, endoscopy, and gastrointestinal surgery.
Annual global conference for interdisciplinary, clinical nutrition leaders, providing the latest in clinical nutrition research, education, and products.